Digital Content 
NEWS #PharmaBuzz
22 Jan 2025
// PRESS RELEASE
https://www.investor.jnj.com/news/news-details/2025/SPRAVATO-esketamine-approved-in-the-U.S.-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression/default.aspx
08 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf
07 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hope-therapeutics-inc-and-nrx-pharmaceuticals-inc-nasdaqnrxp-announce-dr-jonathan-javitt-and-dr-david-feifel-to-present-keynote-address-beyond-ketamine-monotherapy-combined-interventional-treatment-of-suicidal-depressi-302344042.html
26 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/26/2987445/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html
19 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/19/2983534/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html
30 Sep 2024
// CONTRACT PHARMA
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-completion-of-twelve-months-of-stability-on-the-first-manufactured-commercial-scale-lot-of-nrx-100-ketamine-302262032.html
Share 